KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $970,000 | +15.1% | 21,625 | +43.3% | 0.36% | +14.9% |
| Q3 2016 | $843,000 | +144.3% | 15,095 | +118.9% | 0.32% | +128.3% |
| Q2 2016 | $345,000 | -63.3% | 6,895 | -66.3% | 0.14% | -63.3% |
| Q1 2016 | $939,000 | -42.2% | 20,460 | -22.4% | 0.38% | -41.7% |
| Q4 2015 | $1,624,000 | +175.3% | 26,360 | +148.7% | 0.64% | +159.0% |
| Q3 2015 | $590,000 | – | 10,600 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|